Stage

Language

Morning/afternoon

🌍 All (76)✨ Highlights (8)⚙️ Data Foundations (12)🔎 Diagnosis & diseases management (12)🔮 Future of AI for Health (12)💙 Innovative ecosystem (17)📕 Regulatory & Data Governance (5)🔬 Research & Clinical Trials (12)

Nov 16th

9:55 am CET - 10:10 am CET

Startups Masterclass Stage

🇬🇧 How to revolutionize the use of health data without compromising on confidentiality?

Innovation Manager & W.INN Manager

Nov 16th

10:10 am CET - 10:25 am CET

Startups Masterclass Stage

🇬🇧 How to bring a medical device software to the US market?

Sim&Cure launched its medical device software Sim&Size (Class IIa) in Europe in early 2018. In 2019, the goal was to scale to the US market with a lot of topics to go...

10:40 am CET - 11:05 am CET

Mainstage

🇬🇧 From market access to the evaluation of AI-based medical devices: a regulatory adventure

Marion Abecassis

DLA Piper

Attorney in Life Sciences

Novartis BIOME Germany

Novartis BIOME Germany Lead

Jérôme Fabiano

EIT Health France

Public Affairs Director

Eleonora Harwich

NewMarket Strategy

Director and member of the British Standards Institution’s Committee on Artificial Intelligence

Nov 16th

11:50 am CET - 12:00 pm CET

Startups Masterclass Stage

🇬🇧 AI Act – Focus on Human Oversight

3:55 pm CET - 4:05 pm CET

Startups Masterclass Stage

🇬🇧 Validation of commercial AI products at local clinical sites

Understanding the performance of an AI product is an important precursor to deciding on adoption. While summary performance statistics are reported for Regulation, it...

Kanwal Bhatia

Meta-Lynx

Founder

REPLAYS AI FOR HEALTH SUMMIT 2022

🇬🇧 How to revolutionize the use of health data without compromising on confidentiality?

🇬🇧 How to bring a medical device software to the US market?

🇬🇧 From market access to the evaluation of AI-based medical devices: a regulatory adventure

🇬🇧 AI Act – Focus on Human Oversight

🇬🇧 Validation of commercial AI products at local clinical sites

powered by